Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor S Lukashevich

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Expert Review of Vaccines|December 22, 2012
The search for animal models for Lassa fever vaccine developmentIgor S Lukashevich
Viruses|December 4, 2012
Advanced vaccine candidates for Lassa feverIgor S Lukashevich
Expert Review of Vaccines|May 4, 2016
Vaccine platforms to control Lassa feverIgor S Lukashevich, Peter Pushko
Viruses|April 30, 2021
Special Issue "Arenaviruses 2020"Igor S Lukashevich, Juan Carlos de la Torre
Virus Genes|December 5, 2006
Molecular characterization of a reassortant virus derived from Lassa and Mopeia virusesDmitry A Moshkoff, Maria S Salvato, Igor S Lukashevich
Pathogens (Basel, Switzerland)|January 18, 2019
Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1<sup>-/-</sup> MiceDylan M Johnson, Jenny D Jokinen, Igor S Lukashevich
Viruses|March 28, 2024
Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and FlavivirusesPeter Pushko, Igor S Lukashevich, Dylan M Johnson, et al.
Expert Review of Vaccines|April 8, 2016
DNA-launched live-attenuated vaccines for biodefense applicationsPeter Pushko, Igor S Lukashevich, Scott C Weaver, et al.
F1000Research|February 19, 2019
Lassa virus diversity and feasibility for universal prophylactic vaccineIgor S Lukashevich, Slobodan Paessler, Juan Carlos de la Torre
Vaccine|December 31, 2017
Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsMin Wang, Jenny Jokinen, Irina Tretyakova, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Expert Review of Vaccines|December 22, 2012
The search for animal models for Lassa fever vaccine developmentIgor S Lukashevich
Viruses|December 4, 2012
Advanced vaccine candidates for Lassa feverIgor S Lukashevich
Expert Review of Vaccines|May 4, 2016
Vaccine platforms to control Lassa feverIgor S Lukashevich, Peter Pushko
Viruses|April 30, 2021
Special Issue "Arenaviruses 2020"Igor S Lukashevich, Juan Carlos de la Torre
Virus Genes|December 5, 2006
Molecular characterization of a reassortant virus derived from Lassa and Mopeia virusesDmitry A Moshkoff, Maria S Salvato, Igor S Lukashevich
Pathogens (Basel, Switzerland)|January 18, 2019
Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1<sup>-/-</sup> MiceDylan M Johnson, Jenny D Jokinen, Igor S Lukashevich
Viruses|March 28, 2024
Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and FlavivirusesPeter Pushko, Igor S Lukashevich, Dylan M Johnson, et al.
Expert Review of Vaccines|April 8, 2016
DNA-launched live-attenuated vaccines for biodefense applicationsPeter Pushko, Igor S Lukashevich, Scott C Weaver, et al.
F1000Research|February 19, 2019
Lassa virus diversity and feasibility for universal prophylactic vaccineIgor S Lukashevich, Slobodan Paessler, Juan Carlos de la Torre
Vaccine|December 31, 2017
Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsMin Wang, Jenny Jokinen, Irina Tretyakova, et al.
Pageof 6